# Buprenorphine

NDC: 50742-376
Generic name: Buprenorphine
Labeler / Manufacturer: INGENUS PHARMACEUTICALS, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20231101

FDA application: ANDA210272

## Active ingredients

- BUPRENORPHINE: 20 ug/h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50742-376"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50742-376
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=186e3be6-8bc0-4bb9-96f5-429d53632f45